Found 10 matching trials
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis
PHASE2Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis...
A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers
PHASE1A Single-center, Randomized, Blinded, Placebo- and Active-controlled Crosso...
Location
Cliantha Research Limited
Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)
PHASE2This is a phase 2A, single center, open-label, single-arm, 24-week study to...
Location
Virginia Commonwealth University
Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US
PHASE2Saroglitazar Magnesium 4 mg for NAFLD in People Living with HIV in the US...
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
PHASE2This is a randomized, double-blind, placebo-controlled study in up to 104 p...
Location
Precision Research
Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis
PHASE2This is a randomized, double-blind, placebo-controlled study to evaluate sa...
Location
Southern Therapy and Advanced Research (STAR) LLC
Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
PHASE2To evaluate the safety and efficacy of Saroglitazar Magnesium 1, 2, and 4 m...
Location
Medical Affiliated Research Center, Inc.
Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII)
PHASE2This is a multicenter, phase 2A, randomized, double-blind, placebo-controll...
Hepatic Impairment, Cholestatic Liver Disease, & NASH with Advanced Fibrosis & Normal Hepatic Function
PHASE1This will be a Phase 1, Open-label Study of Participants with Hepatic Impai...
Location
Indiana University School of Medicine
Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis
PHASE2prospective, multicenter, randomized, double-blind, placebo-controlled stud...
Location
California Liver Research Institute